Carrie Brownstein is Chief Medical Officer of Cellectis SA. Dr. Brownstein is also on the board of Shattuck Labs, Inc.
In the past she was Executive Director-Clinical Sciences Oncology at Regeneron Pharmaceuticals, Inc., VP-Global Clinical Research & Development at Celgene Corp. and Senior Director-Medical at Roche Pharmaceuticals, Inc.
Dr. Brownstein received a doctorate from Tufts University School of Medicine and an undergraduate degree from the University of Michigan.
|